The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Christopher Young

Tel:
Work +1 619 699 4748
Email:
DLA Piper LLP (US)

Work Department

Litigation

Position

Partner and Co-Chair of DLA Piper's US Product Liability and Mass Torts Practice

Career

Christopher Young is an experienced trial lawyer who acts as co-chair of the firm's Product Liability and Mass Torts practice. Christopher concentrates his practice in the defense of consumer class action litigation, product liability and mass tort litigation, and pharmaceutical and medical device litigation. His clients include life sciences companies, consumer product manufacturers, food and beverage companies, educational institutions, transportation companies and others. Christopher represents clients on a local, national and global basis and has extensive experience with the use of various forms of technology to coordinate and support complex mass tort litigation.

Member

Defense Research Institute (DRI); Barrister, Louis M. Welsh Chapter, American Inns of Court; San Diego County Bar Association

Education

JD, University of California at Berkeley; BA, Pomona College


United States: Dispute resolution

Product liability, mass tort and class action: automotive/transport

Within: Product liability, mass tort and class action: automotive/transport

Philadelphia-based Raymond Williams and Christopher Young in San Diego co-head DLA Piper LLP (US)’s nationwide product liability and mass torts practice. The team advises OEMs, such as Porsche and Ford, on contentious and non-contentious matters, including risk mitigation, product recalls and litigation. Other key figures in the department are James Brogan in Philadelphia and Joel Dewey in Baltimore.

[back to top]

Product liability, mass tort and class action: consumer products (including tobacco)

Within: Product liability, mass tort and class action: consumer products (including tobacco)

The consumer and industrial product liability practice at DLA Piper LLP (US) handles contentious and non-contentious work, such as risk mitigation, regulatory law matters, product recalls and product liability litigation. The group is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, who is particularly experienced in the life sciences, food and beverage industries.

[back to top]

Product liability, mass tort and class action: pharmaceuticals and medical devices - defense

Within: Product liability, mass tort and class action: pharmaceuticals and medical devices - defense

DLA Piper LLP (US)’s pharmaceutical and medical device practice is jointly headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and handles sector-related product liability litigation and mass torts. Williams and New York-based Loren Brown continue to act as national counsel for Novo Nordisk in all litigation arising from claims alleging that some type 2 diabetes treatments can cause pancreatic cancer and pancreatitis. In other ongoing work, Brown defends Pfizer in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. Together with Boston-based Matthew Holian, Brown also represents Bristol-Myers Squibb and Pfizer in an MDL involving claims that anticoagulant medication Eliquis causes bleeding. Bayer, Medtronic and Biogen are also clients of the firm. Cara Edwards in New York is another name to note and Boston-based Jessica Wilson was invited to partnership in January 2017.

[back to top]

Product liability, mass tort and class action: toxic tort - defense

Within: Product liability, mass tort and class action: toxic tort - defense

Jointly headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, the product liability and mass torts practice at DLA Piper LLP (US) is primarily active in asbestos litigation. Led by Boston-based Matthew Holian and John Wellschlager in Baltimore, the team continues to act as national counsel for BASF Catalyst in asbestos litigation related to its predecessor Engelhard and recently won a summary judgment in favor of the client in Fields v Ford Motor Company. Porsche, Exxon Mobil and NJOY are also clients of the firm.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to